Weidinger, Stephan, Andrew Pink, Juan Francisco, Azra Kurbasic, Christina Olsen, Andreas Vilsbøll, and Marjolein de Bruin Weller. “Tralokinumab Improves Clinically Relevant Outcome Measures: A Post Hoc Analysis of ECZTRA 3, A Randomized Clinical Trial in Patients With Moderate-To-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s100. Accessed January 24, 2021. https://jofskin.org/index.php/skin/article/view/1077.